The effect of different combinations of vascular, dependency and cognitive endpoints on the sample size required to detect a treatment effect in trials of treatments to improve outcome after lacunar and non-lacunar ischaemic stroke
Author(s) -
Stephen Makin,
Fergus Doubal,
Terence J. Quinn,
Philip M. Bath,
Martin Dennis,
Joanna M. Wardlaw
Publication year - 2017
Publication title -
european stroke journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 16
eISSN - 2396-9881
pISSN - 2396-9873
DOI - 10.1177/2396987317728854
Subject(s) - lacunar stroke , medicine , stroke (engine) , dementia , montreal cognitive assessment , cognition , vascular dementia , sample size determination , cardiology , randomized controlled trial , physical therapy , vascular disease , ischemic stroke , ischemia , disease , psychiatry , mechanical engineering , statistics , mathematics , engineering
Endpoints that are commonly used in trials of moderate/severe stroke may be less frequent in patients with minor, non-disabling stroke thus inflating sample sizes. We tested whether trial efficiency might be improved with composite endpoints.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom